Pine Pharmaceuticals, LLC: Drug Recall

Recall #D-0050-2024 · 10/02/2023

Class II: Risk

Recall Details

Recall Number: D-0050-2024
Classification: Class II
Product Type: Drug
Recalling Firm: Pine Pharmaceuticals, LLC
Status: Terminated
Date Initiated: 10/02/2023
Location: Tonawanda, NY, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 2862 Syringes

Reason for Recall

Lack of Assurance of Sterility

Product Description

Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Distribution Pattern

Nationwide within the United States

Other Recalls by Pine Pharmaceuticals, LLC

Class II: Risk 10/02/2023

Lack of Assurance of Sterility
Class II: Risk 10/02/2023

Lack of Assurance of Sterility
Class II: Risk 10/02/2023

Lack of Assurance of Sterility
Class II: Risk 10/02/2023

Lack of Assurance of Sterility
Class II: Risk 10/02/2023

Lack of Assurance of Sterility

View all recalls by Pine Pharmaceuticals, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.